Related Experiment Video

Updated: May 17, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Update on global intervention studies in type 1 diabetes

Jane L Chiang1, Michael J Haller, Desmond A Schatz

  • 1Division of Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA 94305, USA. jane.chiang0@gmail.com

Endocrinology and Metabolism Clinics of North America
|October 27, 2012
PubMed

Insights

Preventing type 1 diabetes involves complex gene, immune, and environmental interactions. While progress in arresting pancreatic beta-cell destruction is notable, a safe cure remains elusive, necessitating refined trial designs.

Area of Science:

  • Immunology
  • Endocrinology
  • Genetics

Background:

  • Type 1 diabetes involves progressive pancreatic beta-cell destruction.
  • Despite advances, safe and effective therapeutic interventions are lacking.
  • The etiology is multifactorial, involving genetic predisposition, immune dysregulation, and environmental triggers.

Purpose of the Study:

  • To update principles for designing type 1 diabetes prevention and intervention trials.
  • To review existing clinical trials for type 1 diabetes.
  • To provide a framework for future research to halt disease progression.

Main Methods:

  • Review of current scientific literature on type 1 diabetes.
  • Analysis of principles guiding prevention and intervention trial design.
  • Examination of completed and ongoing clinical studies.

Main Results:

  • Significant progress in understanding disease mechanisms but no definitive cure.
  • Challenges in developing safe and effective therapies persist.
  • Need for optimized trial designs to evaluate potential interventions.

Conclusions:

  • Interdicting type 1 diabetes requires a comprehensive approach.
  • Future research should focus on refined trial strategies.
  • Addressing the complex interplay of factors is key to finding a cure.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...